Medi Caps Quarterly Results for Trading Insights
MEDICAPQ • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-2 Cr
QSept 2025
Medi Caps Quarterly Results Key Highlights
- Revenue of ₹4 Cr in Sept 2025 (-55.6% vs Mar 2025, -55.6% vs Sept 2024)
- Net Profit of ₹-2 Cr in Sept 2025 (-200.0% vs Mar 2025)
- EBITDA of ₹-1 Cr in Sept 2025 (-150.0% vs Mar 2025)
- Operating Margin of -145.0% in Sept 2025 (-141.0pp vs Mar 2025)
- Earnings Per Share of ₹-1.46 in Sept 2025 (-205.8% vs Mar 2025)
Medi Caps Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 4 | 9 | 3 | 5 | 9 | -55.6% | -55.6% |
| Net Profit (₹ Cr) | -2 | 2 | -4 | -1 | 0 | - | - |
| EBITDA (₹ Cr) | -1 | 2 | -3 | 0 | 1 | - | - |
| EPS (₹) | -1.46 | 1.38 | -2.80 | -0.61 | 0.25 | - | - |
| Operating Margin (%) | -145.0% | -4.0% | -126.0% | -25.0% | 5.0% | - | - |
Medi Caps Share Price Trend Around Quarterly Results
Visualize Medi Caps's 1-year price movement across quarterly results — ideal for logging trades in Medi Caps share price
chart using Tickjournal. All values in ₹.
Related Pages for Medi Caps
Additional stock information and data for MEDICAPQ
Revenue Trend (₹ Cr)
Dec 2025
5
Jun 2025
3
Mar 2025
9
Sept 2025
4
Net Profit Trend (₹ Cr)
Dec 2025
-1
Jun 2025
-4
Mar 2025
2
Sept 2025
-2
Operating Margin Trend (%)
Dec 2025
-25.0%
Jun 2025
-126.0%
Mar 2025
-4.0%
Sept 2025
-145.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Medi Caps quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹416,764.48 Cr | 1807.4 | 14,875 | 3,125 | +10.8% | - | 21.0% | 139.0 |
|
Divis Laboratories
Sept 2025 |
₹170,125.54 Cr | 6330.0 | 2,860 | 689 | +7.1% | - | 24.1% | 243.7 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹146,658.56 Cr | 4373.7 | 3,219 | 591 | +11.3% | - | 18.4% | 249.4 |
|
Cipla
Sept 2025 |
₹109,178.44 Cr | 1325.0 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.2 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,358.50 Cr | 1287.0 | 9,135 | 1,337 | +1.1% | - | 14.6% | 79.5 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores